Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials

Tirzepatide is a novel once-a-week dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, currently under trial to assess glycemic efficacy and safety in people with type 2 diabetes. A systematic review and meta-analysis were conducted to investigate the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhagavathula, Akshaya Srikanth, Vidyasagar, Kota, Tesfaye, Wubshet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537322/
https://www.ncbi.nlm.nih.gov/pubmed/34681215
http://dx.doi.org/10.3390/ph14100991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537322/
https://www.ncbi.nlm.nih.gov/pubmed/34681215
http://dx.doi.org/10.3390/ph14100991

Ejemplares similares